We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 858

CSA and CDS Clarify Positions in Response to Recent Developments in U.S. Cannabis Laws and the Sessions Memorandum
  • Torkin Manes LLP
  • Canada
  • February 19 2018

Torkin Manes LLP published an article in November 2017 that provided guidance on the treatment of public issuers with U.S. cannabis-related

2018 Real Estate Update: Trending Issues & Topics of Interest
  • Greenbaum, Rowe, Smith & Davis LLP
  • USA
  • February 15 2018

2018 Real Estate Update: Trending Issues & Topics of Interest Greenbaum, Rowe, Smith & Davis LLP Client Alert February 2018 Each year, the

Will Kratom Be Restricted?
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 14 2018

Kratom, a popular alternative medicine used as a home remedy for opioid addiction, is now classified by the Food and Drug Administration ("FDA") as an

SCOTUS Could Take Up 280E
  • Duane Morris LLP
  • USA
  • February 7 2018

There may be no greater thorn in the side of a cannabis producer, processor or retailer than section 280E of the Internal Revenue Code. Section 280E

FDA Accepting Comments on CBD for UN Commission Meeting
  • Duane Morris LLP
  • USA
  • January 26 2018

The Food and Drug Administration (FDA) is accepting comments to help formulate the United States' position on the World Health Organization's

As Congress Struggles With ACA Repeal, Trump Administration Moves Forward With Regulatory Reform
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • January 23 2018

The Trump administration and Republican-led Congress spent substantial time and political capital in 2017 on efforts to repeal and replace the

Sessions’s Marijuana Memo Reminds Colorado Employers They Are Not Out of the Federal Weeds
  • Wilson Elser
  • USA
  • January 23 2018

Attorney General Jeff Sessions’s January 4, 2018, Memorandum for All U.S. Attorneys explicitly rescinds all prior nationwide guidance on

Attorney General Jeff Sessions Reverses Course on Marijuana Enforcement
  • Ogletree Deakins
  • USA
  • January 19 2018

On January 4, 2018, Attorney General Jeff Sessions reversed the Department of Justice’s (DOJ) position on enforcement of federal marijuana laws

AG Kills the Buzz for Marijuana Businesses
  • Manatt Phelps & Phillips LLP
  • USA
  • January 18 2018

Banks face even greater risks and are likely to back away from marijuana-related businesses after the U.S. Attorney General changed the federal

Justice Department reverses course on marijuana enforcement: What it means for employers
  • Nexsen Pruet
  • USA
  • January 17 2018

Attorney General Jeff Sessions recently issued a guidance memorandum rescinding several Obama-era Justice Department memoranda regarding federal